EUVIMEDEUVIMED entdecken
Delphi-Studie

Current Indications for Thrombophilia Testing – A Modified Delphi Consensus Study in Switzerland

Alessandra Bosch iD, Cosima Suter, Lukas Graf, Sabine Ruosch-Girsberger

Hämostaseologie · 30.04.2026

DOI: 10.1055/a-2858-0105 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Hämostaseologie, erschienen am 30.04.2026. Verfasst von Alessandra Bosch und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Children's Hospital Zürich, Haematology, ZH, Switzerland, Zurich.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thrombophilia is a hereditary or acquired condition associated with an increased risk of venous thromboembolism (VTE) and VTE recurrence. Existing recommendations on patient selection vary across guidelines, resulting in variability of testing practices. This heterogeneity reflects persistent uncertainty regarding appropriate testing strategies in routine care.This modified Delphi survey was conducted to establish expert consensus on clinical indications for thrombophilia testing in Switzerland.

Methods

A modified Delphi study was performed with clinical experts managing patients with VTE in Switzerland. A steering committee developed clinical scenarios and statements on thrombophilia testing. These were distributed to the expert panel who rated their agreement and provided written feedback in two rounds. Consensus was defined as ≥70% of experts rating a statement ≥5 on a 7-point Likert scale.

Results

Forty-two clinical experts completed the survey. Consensus was reached after two rounds on 32 statements addressing indications for thrombophilia testing in various clinical scenarios, including unprovoked VTE, provoked VTE (including hormone-associated events), unusual site VTE, pediatric VTE, and patients without VTE. For example, consensus supported thrombophilia testing in patients aged

Autor:innen und Institutionen

  • University Children's Hospital Zürich, Haematology, ZH, Switzerland, Zurich.
  • University Hospital Zurich, Medical Oncology and Haematology, ZH, Switzerland, Zürich.
  • Sankt Gallen Centre for Laboratory Medicine, Eastern Switzerland Haemophilia and Haemostasis Centre, SG, Switzerland, St. Gallen.
  • Cantonal Hospital of Lucerne, Haematology, Switzerland, Lucerne.

ORCID-Profile: Alessandra Bosch

Zitieren

APA

Bosch, A., Suter, C., Graf, L., & Ruosch-Girsberger, S. (2026). Current Indications for Thrombophilia Testing – A Modified Delphi Consensus Study in Switzerland. Hämostaseologie. https://doi.org/10.1055/a-2858-0105

Vancouver

Bosch A, Suter C, Graf L, Ruosch-Girsberger S. Current Indications for Thrombophilia Testing – A Modified Delphi Consensus Study in Switzerland. Hämostaseologie. 2026. doi:10.1055/a-2858-0105

BibTeX
@article{Bosch2026,
  author = {Bosch, Alessandra and Suter, Cosima and Graf, Lukas and Ruosch-Girsberger, Sabine},
  title = {Current Indications for Thrombophilia Testing – A Modified Delphi Consensus Study in Switzerland},
  journal = {Hämostaseologie},
  year = {2026},
  doi = {10.1055/a-2858-0105}
}
Kostenlos starten →